Greater Glasgow & Clyde
   |
CANCER AND ONCOLOGY RESEARCH
By using cutting edge technology, this collaborative study - working together with clinical trial groups and with support from Cancer Research UK - will analyse epigenetic markers in cell DNA (methylation) to gather information fro the detection and treatment of cancers of the lung, breast and ovaries. Signs of abnormal methylation often indicate cancerous cells and the study will compare these cells with normal cells to identify how methylation can provide novel information about the pathology of tumours.
This research has the potential to substantially change the way physicians first diagnose and later treat cancer patients. By analysing methylation of tumour cells it may be possible for doctors to choose the most appropriate form of treatment, thus helping get more effective drugs into patients quicker and reducing the risk of time wasted on ineffective treatments. The methylation technologies may prove to be extremely powerful in helping improve the outcome for cancer patients, particularly in clinical trails of novel agents.
Key Contacts
Paul G Ellis
Senior Contracts Manager
Research & Enterprise
University of Glasgow
10 The Square
GLASGOW G12 8QQ
Tel: +44 (0)141 330 3875
Fax: +44 (0)141 330 5611
Click
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
to email
Jacqueline Coffield,
Translational Research Officer,
Faculty of Medicine,
Wolfson Medical School Building,
University of Glasgow,
University Avenue,
Glasgow, G12 8QQ
Tel: +44 (0)141330 8147
Fax: +44 (0)141 330 5440
Click
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
to email